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Abstract 
Mutations in VPS35 (PARK17) FDXVHDXWRVRPDOGRPLQDQWODWHRQVHW3DUNLQVRQ¶V
disease (PD). VPS35 forms a core component of the retromer complex that mediates 
the retrieval of membrane proteins from endosomes back to either the Golgi or plasma 
membrane. While aberrant endosomal protein sorting has been linked to several 
neurodegenerative diseases the mechanisms by which VPS35 mutations and retromer 
function contribute to PD pathogenesis are not clear. To address this we generated 
transgenic Drosophila that express variant forms of human VPS35 found in PD cases 
and the corresponding variants of the Drosophila ortholog. We did not find evidence 
of dominant toxicity from any variant form including the pathogenic D620N mutation, 
even with aging. However, assessing the ability of Vps35 variants to rescue multiple 
vps35 mutant phenotypes we found that the D620N mutation confers a partial loss of 
function. Recently, VPS35 has been linked to the formation of mitochondria derived 
vesicles, which mediate the degradation of mitochondrial proteins and contribute to 
mitochondrial quality control. This process is also promoted by two other PD-lined 
genes parkin (PARK2) and PINK1 (PARK6). We demonstrate here that vps35 
genetically interacts with parkin but interestingly not with pink1. Strikingly, Vps35 
overexpression is able to rescue several parkin mutant phenotypes. Together these 
findings provide in vivo evidence that the D620N mutation likely confers 
pathogenicity through a partial loss of function mechanism, and that this may be 
linked to other known pathogenic mechanisms such as mitochondrial dysfunction.  
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Introduction 
3DUNLQVRQ¶VGLVHDVH3'LVDFRPPRQQHXURGHJenerative disorder that is principally 
characterized by the progressive loss of motor control and degeneration of 
dopaminergic neurons in the basal ganglia. Although current treatments provide 
temporary symptomatic relief, their efficacy declines and the condition is currently 
incurable. A greater understanding of the pathogenic mechanisms would allow the 
development of more rational disease-modifying interventions. In recent years genetic 
analysis of mendelian forms of PD has shed tremendous light on the molecular 
players in pathogenesis. Recently, a mis-sense mutation, Asp620Asn (D620N), in 
VPS35 (PARK17) was identified in a number of families with dominantly inherited, 
late-onset PD (1, 2). Additional variants, including P316S, R524W and L774M, have 
also been found in sporadic patients but their presence also in unaffected controls has 
rendered the pathogenicity of these uncertain (1, 2).  
VPS35 is a central component of the highly conserved retromer complex that 
mediates the retrieval of transmembrane cargo-proteins from endosomes (3, 4). 
Cargo-selective sorting is critical for regulating the proper sub-cellular destination of 
endosomal proteins. The most widely characterized role for retromer is in the 
recycling of transport proteins, such as the cation-independent mannose 6-phosphate 
receptor (5) or Wnt transport protein Wntless (6-8), back to the trans-Golgi network 
(TGN). More recently, the cargo-selective retromer complex has also been shown to 
recruit the actin nucleation promoting WASH complex to endosomes (9-11), 
mediated directly via VPS35 (12).  This promotes the recycling of specific cargo, 
such as tKHȕ2-adrenergic receptor and the glucose transporter GLUT1, directly back 
to the plasma membrane (13).  
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Current literature on the impact of the pathogenic D620N mutation on 
retromer function present conflicting results on whether endosome-to-TGN and/or 
endosome-to-plasma membrane recycling is affected (14-16), or in fact whether 
VPS35 variants confer dominant toxicity or are functionally hypomorphic (14, 17, 18). 
However, recent studies have revealed that the pathogenic D620N mutation inhibits 
VPS35 binding to the actin-nucleating Wiskott-Aldrich syndrome and SCAR 
homolog (WASH) complex, consistent with a partial loss of function (15, 16). 
Nevertheless, much still remains to be clarified on the pathogenic nature of VPS35 
mutations and the mechanism(s) by which they cause neurotoxicity, especially in vivo.  
A surprising development in the emerging complexity of retromer function 
was the report that Vps35 appears to mediate the formation and trafficking of 
mitochondria derived vesicles (MDVs) (19). Similar to endosomes, these MDVs are 
also cargo-selective and have a variety of destinations, including peroxisomes and 
lysosomes (19, 20). The precise role of these MDVs is currently uncertain but is 
likely to provide a route for mitochondrial component degradation and thus a 
mechanism of mitochondrial quality control (20, 21). Moreover, recent evidence 
indicates that two genes causative for autosomal recessive parkinsonism, PINK1 
(PARK6) and parkin (PARK2), promote the formation of cargo-specific MDVs 
targeted for lysosomal degradation (22), implicating this process in the pathogenesis 
of PD.  
Here we sought to develop a simple in vivo model of VPS35 related PD using 
Drosophila in order to address the relative pathogenicity of known variants and to 
shed light on the possible pathogenic mechanisms. Expressing variant forms of 
human VPS35 or the equivalent mutations in Drosophila vps35 we found no evidence 
of dominant toxicity, even with ageing. In contrast, all variants functioned similar to 
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wild type, being able to substantially rescue vps35 mutant phenotypes including one 
assay of endosome-to-TGN recycling. However, some assays showed that mutant 
Vps35 functioned less well than wild type, suggesting they may be hypomorphic. 
Interestingly, we observed a strong genetic interaction between vps35 and parkin, 
where double heterozygotes presented a synergistic loss of dopaminergic neurons, an 
enhanced climbing defect which was exacerbated with age, and a striking sensitivity 
to paraquat. In genetic rescue experiments, vps35 overexpression substantially 
suppressed several parkin mutant phenotypes but not vice versa. Thus, our genetic 
studies suggest that vps35 variants associated with PD likely confer pathogenicity by 
haploinsufficiency rather than a toxic gain-of-function, and suggest that mitochondrial 
quality control may be an important pathway in vps35 meditated pathogenesis. 
 
Results 
No dominant toxicity from vps35 pathogenic variants 
Vps35 is highly conserved with human and Drosophila protein homologs sharing 
61% identity and 78% similarity (Fig. 1A). To investigate the pathogenicity of vps35 
mutations in vivo we generated transgenic Drosophila that express variant forms of 
human VPS35 or, where these residues are conserved, equivalent variants of 
Drosophila vps35. Since residues R524, D620 and L774 are conserved in Drosophila 
Vps35, while P316 is not, we focussed our analysis on these mutations. Transgenic 
Drosophila were generated that express WT and variant forms of either human or 
Drosophila vps35 under the control of the GAL4/UAS system. Here we designate the 
variants of human VPS35 as hWT, hD620N, h524W and hL774M, while the 
Drosophila equivalent variants are designated dWT, D650N, dR550W and dL800M. 
 at R
oyal H
allam
shire H
ospital on A
ugust 18, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
6 
Expression of the human Vps35 variants was verified by immunoblotting (Fig. 
1B). Reliable antibodies against Drosophila Vps35 are not currently available but we 
assume approximately equivalent expression levels due to the site-specific integration.  
Since VPS35 mutants cause autosomal dominant PD we first assessed whether 
expression of these transgenes caused dominant phenotypes associated with neuronal 
toxicity. We analysed effects on lifespan, retinal degeneration and locomotor activity, 
however, no apparent toxicity was observed from expression of all the transgenes (Fig. 
1C-E). Moreover, no defects in motor ability appeared even after ageing (Fig. 1F, G). 
To enhance expression to physiologically relevant levels (see below) we also raised 
and aged animals at 29oC. Under these conditions, transgenic animals showed a rather 
modest, albeit significant, impairment to lifespan compared to controls, but all Vps35 
variants showed equivalent effects (Supplementary data). However, there was still no 
significant effect on climbing behaviour compared to controls at either 1-4 days or 10 
days old, across all transgenic lines. 
 
Vps35 variants confer partial loss of function 
Since no phenotypes were observed from overexpression in a wild type background, it 
was essential to determine whether the transgenes faithfully replicated Vps35 
functionality. A definitive test is to determine whether transgene expression can 
substitute for endogenous vps35 function by rescuing mutant phenotypes. Loss of 
function mutations in Drosophila vps35 cause severe developmental defects resulting 
in larval stage lethality and the appearance of melanotic masses in various 
homozygous and transheterozygous combinations (6-8). All transgenes were 
expressed in a vps35 transheterozygous mutant background (vps35MH20/vps35E42) and 
viability was determined. Surprisingly, despite using a strong ubiquitous driver, 
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animals raised under standard conditions (25oC) showed no rescue of viability with 
any of the Vps35 variants (data not shown), so we raised animals at a higher 
temperature (29oC) to increase transgene expression levels (Fig. 1B). Expression of 
all variants of Drosophila vps35 was now sufficient to prevent the appearance of 
melanotic masses and fully rescue the developmental lethality, with progeny 
emerging in expected proportions. However, while the human VPS35 variants rescued 
mutant viability to late pupal stage, adults failed to eclose indicating that human 
VPS35 protein cannot fully substitute for the Drosophila orthologue. In light of these 
results, all subsequent rescue experiments were performed with animals grown at 
29oC.   
vps35 mutants show defective development of the neuromuscular junction 
(NMJ), caused in part by aberrant BMP signalling. Loss of vps35 leads to the 
formation of supernumerary boutons (Fig. 2A-B). This developmental defect in the 
NMJ is accompanied by a dramatic reduction in the larval locomotion (Fig. 2C). 
Expression of all variants of Drosophila and human Vps35 was able to completely 
restore normal NMJ formation (Fig. 2A-B). However, the larval locomotion defect 
showed a more variable response (Fig. 2C). While the expression of WT dVps35 
could completely restore locomotion to control levels, expression of WT hVps35 
could also substantially rescue this deficit. In contrast, the missense variants of both 
dVps35 and hVps35 could only partially substitute for loss of vps35 for this 
phenotype.  
The ability of the Drosophila transgenes to successfully rescue vps35 mutant 
viability allowed us to further test the relative functionality of the mutant variants 
using the climbing assay. This higher-order behavioural test revealed that expression 
of the dWT or dL800M variant enabled comparable climbing capacity compared to 
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8 
controls (Fig. 2D). In contrast, the dD650N pathogenic mutation, and to a lesser 
extent the dR550W variant, produced a clear climbing defect  (Fig. 2D). 
The retromer function of Vps35 has been shown to regulate the secretion of 
Wg in the larval wing imaginal disc. Failure of the retromer complex to recycle the 
Wg transporter protein Wntless leads to an intracellular accumulation of Wg and 
concomitant signalling defects. This can be observed by increased immunostaining of 
Wg in vps35 mutant clones compared with neighbouring wild type tissue (Fig. 3A-B), 
as previously reported. To further test the relative function of Vps35 variants we 
sought to determine how well they could restore Wg levels in vps35 mutant wing 
discs. To allow comparison within the same tissue, we analysed wing discs from 
vps35 mutant animals in which Vps35 transgene expression was restricted to the 
posterior compartment via induction with hedgehog-GAL4 (Fig. 3C). While the 
expression of all transgenes reduced the aberrant Wg levels, quantification across 
multiple samples showed that all variants restored the levels Wg to a similar degree 
(Fig. 3D).  
Taken together, the preceding results indicate that not only do the Vps35 
variants appear to not confer any major dominant toxicity, but all variants appear to 
function largely normally in endosome-to-plasma membrane recycling. However, 
while NMJ structural defects are restored by all Vps35 variants, in functional 
locomotor assays the pathogenic variants consistently reveal a partial loss of function. 
 
vps35 genetically interacts with parkin but not pink1 
Since our analysis of transgenic Vps35 variants provided no evidence for a toxic 
pathologic mechanism in our model system, we next sought to determine whether 
vps35 mutations may influence other pathogenic causes. One putative link came from 
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9 
the observations that Vps35 appears to play a role in the generation of mitochondria 
derived vesicles (MDVs). Importantly, this process was also recently linked to PINK1 
and parkin, two autosomal recessive PD genes strongly implicated in mitochondrial 
quality control. MDVs have been proposed to function as part of the quality control 
mechanism as some vesicles carrying oxidised protein cargoes are trafficked to the 
lysosome for degradation. Thus, we tested whether vps35 may genetically interact 
with parkin and pink1.  
Animals heterozygous for vps35 or parkin show no phenotype compared to 
wild type, however, we found a significantly worse climbing ability in 
vps35/+;parkin/+  double heterozygotes, analysing two independent alleles of vps35 
(Fig. 4A-F). Interestingly, this synergy was age-dependent; not apparent in young 
animals but worsening in older animals. These observations suggest that parkin and 
vps35 may partly act in a common pathway, and one that is an age-related process.  
Oxidative stress is a prominent feature of PD pathology and of normal ageing. 
Many models of PD show sensitivity to oxidative stressors such as paraquat, 
including Drosophila parkin mutants (Fig. 4G). Similar to the locomotor assay, while 
the single heterozygotes were relatively insensitive, we found a synergistic sensitivity 
of vps35/+;parkin/+  double heterozygotes to paraquat exposure, comparable in 
severity to parkin homozygotes (Fig. 4G). Interestingly, we also saw a genetic 
interaction of vps35 and parkin in the degeneration of DA neurons of the PPL1 cluster 
after 30 days (Fig. 4H).  
Since combining loss of function mutations caused the appearance of 
pathogenic phenotypes, we reasoned that overexpression of either vps35 or parkin 
may ameliorate mutant phenotypes of the other gene. vps35 mutants are 
developmental lethal and present characteristic melanotic masses in larvae (7). Strong, 
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10 
ubiquitous overexpression of parkin in vps35 mutants was unable to rescue these 
phenotypes (data not shown). However, we found that overexpression of vps35 
significantly rescued many of the parkin phenotypes, including the climbing defect 
and sensitivity to paraquat (Fig. 5A, C-D), with all variants of either Drosophila of 
human Vps35 providing an equivalent degree of rescue. In contrast, the flight defect 
in parkin mutants was not suppressed by vps35 overexpression (Fig. 5B). 
Substantial evidence supports a role for PINK1 and parkin to act, at least 
partly, in a common pathway, so we also tested for genetic interaction between vps35 
and pink1. In contrast to the previous results we found no synergy in vps35/+;pink1/+  
double heterozygotes, even after ageing (Fig. 6A-F). We also found vps35 
overexpression did not rescue pink1 phenotypes (Fig. 6G, H, and data not shown), nor 
did pink1 overexpression alter vps35 phenotypes (data not shown). In fact, while 
vps35 overexpression did not alter the pink1 climbing defect, it actually worsened the 
flight defect (Fig. 6H). Thus, while the preceding results indicate a strong genetic 
interaction between vps35 and parkin, surprisingly, there appears to be no genetic 
interaction between vps35  and pink1.  
 
Discussion 
Mutations in VPS35 cause a late-onset, autosomal dominant form of PD. Replicating 
genetic mutations in classic model systems has been a powerful approach in 
illuminating the pathogenic mechanisms. One key issue in the molecular 
understanding of pathogenicity, especially with mutations causing dominant forms of 
disease, is to determine the basic mode of toxicity which can be broadly predicted to 
be toxic gain-of-function, dominant-negative and/or haploinsufficiency through 
partial loss of function.  
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11 
Current literature analyzing the impact of the D620N mutation on the cell 
biological function of the retromer complex present conflicting results as to whether 
endosome-to-TGN and/or endosome-to-plasma membrane recycling is affected (14-
16). However, despite discrepancies on which trafficking routes may be perturbed, 
there is a general consensus that D620N has impaired function compared to WT 
without overt dominant toxicity (14-16, 23). Evidence for the molecular basis of this 
dysfunction indicates that D620N specifically disrupts the recruitment of the WASH 
complex to endosomes by decreased binding of VPS35 to the WASH component 
FAM21 (15, 16). These findings argue for partial loss of function from this 
pathogenic mutation, rather than toxic gain of function. Our results largely support 
these findings. First, our data provide clear evidence that transgenic expression of WT 
or variant forms of vps35 does not cause overt toxicity. Second, all variants of Vps35 
appear to function near normally as they are able to substantially rescue vps35 mutant 
phenotypes, including viability, NMJ morphology and Wg secretion. Interestingly, 
while the WT form of both Drosophila and human Vps35 could substantially rescue a 
larval locomotor defect, the variant forms could only provide partial rescue consistent 
with a partially reduced functionality. Furthermore, although the pathogenic dD650N 
variant could rescue vps35 mutants to adult viability, these animals revealed a distinct 
locomotor deficit in contrast to the WT and non-pathogenic dL800M. The locomotor 
activity assays provide a highly sensitive read-out of the complex neuromuscular 
circuit. Even small disturbances in function at any part of this circuit will result in a 
quantifiable deficit. Thus, the failure of the Vps35 pathogenic variants to fully rescue 
this phenotype likely reflects a subtle decrease in functionality.  
A recent study of lentiviral mediated overexpression of VPS35 in cortical 
neurons reported neurotoxic effects in vitro and in vivo, however, the effects of 
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D620N were often similar to that of overexpressing WT VPS35 (17). Thus, although 
it was proposed that where the effect of D620N overexpression differed from 
overexpression of WT this was due to some gain-of-function toxicity, the effects 
could also result from the reduced function of D620N acting as a partial dominant 
negative when overexpressed. 
The disruption of VPS35 D620N binding to FAM21 suggests a plausible 
pathogenic mechanism since this appears to affect the trafficking of the autophagy 
protein ATG9A and subsequent induction of autophagy (16). Since autophagy is a 
key mechanism for degradation of cellular components such as long-lived proteins, 
large aggregates and defective organelles, autophagy inhibition is considered a major 
culprit in the pathogenesis of neurodegenerative diseases including PD. It is notable 
that VPS35 haploinsufficiency has been reported to enhance neuropathology in a 
mouse model of AlzheLPHU¶VGLVHDVH (24), where amyloid plaques and neurofibrillary 
tangles highlight decreased autophagy as a prominent mechanism for this disease (25). 
In this context, it is highly plausible that the partial loss of function conferred by 
VPS35 mutations may lead to a haploinsufficiency of VPS35 function related to 
autophagy induction in PD as well.  
Partial loss of function could also affect other VPS35 functions. To date, while 
there is very limited evidence linking µFODVVLF¶Uetromer-mediated endosomal retrieval 
in PD, mitochondrial dysfunction has long been considered a key pathogenic 
mechanism (26). Our genetic studies of vps35 with parkin and pink1 supports an 
involvement in Vps35 regulating mitochondrial homeostasis but has yielded some 
surprising results. First, we uncovered a clear genetic interaction between vps35 and 
parkin consistent with the two genes functioning in a common process. Parkin has 
been linked to the regulation of many cellular processes (27), but by far the most 
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13 
prominent is the autophagic degradation of damaged mitochondria, or mitophagy, a 
mechanism of mitochondrial quality control (28). Recently, it was shown that and 
early mechanism of Parkin-mediated mitochondrial homeostasis was in the generation 
of MDVs (22), previously also linked to VPS35 function (19). Clearly more work is 
needed to elucidate the precise mechanisms linking vps35 function to parkin, however, 
our results are consistent with Vps35 and Parkin cooperating in such a mitochondrial 
quality control process and provide the first in vivo evidence for a functional 
interaction.  
Given this robust vps35-parkin genetic interaction, the lack of evidence for a 
genetic interaction between vps35 and pink1 was surprising given the substantial body 
of evidence linking the functions of PINK1 and Parkin (28), and the fact that PINK1 
also appears to promote MDV formation (22). Nevertheless, this result adds further 
weight to the growing evidence that PINK1 and Parkin have independent as well as 
common functions. Most notably, PINK1 has been suggested to regulate the activity 
of Complex I of the respiratory chain independent from its role in mitophagy or 
Parkin (29, 30).  
The characterization of these new Drosophila models of PD provide in vivo 
evidence that dominant mutations in VPS35 likely do not act via a dominant toxic 
gain of function but rather through a partial loss of function conferring an age-
dependent haploinsufficiency. Moreover, our genetic studies provides further support 
for vps35 deficiency impacting on mitochondrial quality control processes. Further 
work will be needed to understand the full spectrum of VPS35 and retromer function 
on cellular homeostasis, but these models provide a platform with which to elucidate 
this in the context of the ageing brain.  
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Material and Methods 
Drosophila genetics 
Drosophila were raised under standard conditions at 25°C on food consisting of agar, 
cornmeal and yeast unless otherwise stated. The UAS-hVPS35 transgenes were 
generated by sub-cloning human VPS35 variants, kindly provided by T. Strom, into 
S8$67DWW%YHFWRUXVLQJSULPHUVLQWURGXFLQJ¶1RW,DQG¶;KR,FORQLQJsites. The 
UAS-dVps35 transgenes were similarly generated by sub-cloning the full length 
Drosophila Vps35 cDNA (clone SD03023 from the Drosophila Genomics Resource 
Center) into pUASTattB. Variants of dVps35 were generated by standard site-directed 
mutagenesis prior to sub-cloning. All constructs were verified by sequencing. 
Transgenic lines were made using the phiC31 method using target strain PBac{y[+]-
attP-3B}VK00031, integrating the transgene at cytological location 62E1 (BestGene 
Inc.). At least 3 lines of each variant were initially tested for consistency before 
focusing on a single line.  
The vps35MH20 and vps35E42 alleles and UAS-vps35-HA have been described 
before (7, 8), and were kindly provided by J-P. Vincent (Crick Institute) and K. Basler 
(IMLS, Zurich). pink1B9 mutants (31) were kindly provided by J. Chung (SNU). 
park25 mutants have been described before (32). Stocks to analyse vps35 function in 
wing discs, hh-GAL4, UAS-RFP, and Ubx-FLP; FRT42D arm-lacZ, were a kindly 
provided by D. Strutt. w1118, da-GAL4 and GMR-GAL4 strains were obtained from the 
Bloomington Drosophila Stock Center (Bloomington, IN). 
 
Behavioural assays 
Fertility tests, flight and climbing assays were performed as previously described (32, 
33), with only males assessed here. Larval crawling was performed using animals 
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grown at 29oC. Third instar larvae expressing the indicated vps35 transgene using da-
GAL4 in the vps35 mutant background, were collected from vials, briefly rinsed with 
distilled water, and placed on 2% agar. Movies were captured which were then 
analysed manually, recording the peristaltic waves per 2 minutes for each larva.  
For lifespan analysis, animals were raised in low density, and shortly 
following eclosion 40-100 adult flies were separated by gender and kept in groups of 
15 flies per vial. The number of deaths were recorded every 2 or 3 days as were 
transferred to new media. Survival upon exposure to paraquat was performed 
similarly, except flies were kept in vials with filter paper soaked with 5 mM paraquat 
in 5% sucrose. Survival was analysed by Log-rank (Mantel-Cox) test. For all the 
experiments, unless otherwise indicated, only males were used. 
 
Immunoblotting 
Proteins were prepared in lysis buffer [50 mM Tris·HCl, 150 mM NaCl, 10% 
(vol/vol) glycerol,1% Triton X-100, 10 mM N-ethylmaleimide, 2 mM EGTA, 1 mM, 
MgCl2, 50 µM MG-132, and protease inhibitor mixture (Roche)], 60 µg were loaded 
on SDS-PAGE gels. After resolving, proteins were transferred onto PVDF membrane. 
Membranes were blocked by 5% skimmed milk, 1% FBS in TBST. Rabbit anti-
VPS35 (Proteintech 10236-1-AP, 1:500) was incubated in blocking solution overnight 
at 4oC. Mouse anti-Actin (Millipore MAB1501, 1:10,000) was incubated in blocking 
solution at RT for 1 h. Membranes were washed repeatedly in PBST, then appropriate 
HRP-conjugated secondary antibodies were incubated for 1 h at RT. Detection was 
achieved with ECL-Plus detection kit (Amersham) using radiographic film.  
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Immunohistochemistry 
Wandering third instar larvae were selected for NMJ analysis essentially as previously 
described (34). Larval body wall muscles were dissected in a saline containing 
(128mM NaCl, 2mM KCl, 4mM MgCl2, 0.1mM CaCl2, 35.5mM Sucrose and 5mM 
Hepes (pH 7.2), and fixed in a freshly prepared ice-cold 4% paraformaldehyde for 20 
min.  
The preparations were then washed in PBS-0.01%Tween 20 (PBST) for three 
times in 15 minutes, followed by 1h blocking in 5% Fetal Bovine Serum in PBST.  
Samples were incubated overnight at 4oC with anti-HRP antibody (Jackson 
Immunoresearch laboratories, used at 1:200) and anti-DLG (4F3, Developmental 
Studies Hybridoma Bank, used at 1:300).  Secondary antibodies (Invitrogen) 
AlexaFluor 594 Goat anti-rabbit (1:500) and AlexaFluor 488 Goat anti-mouse (1:500) 
were used respectively. 
Quantification of bouton number was performed on longitudinal muscle 6/7 at 
segment A2 as previously described (35). Total number of boutons (Type 1B and 1S) 
were counted on Olympus FV1000 microscope under Plan Apo 60X (N.A. 1.42) oil 
immersion lens. The number of boutons were normalized to the respective muscle 
surface area. Muscles were photographed at a 10X magnification and the area was 
quantified using Image J software. 
 Wing discs were analysed essentially as previously described (36). Wandering 
third instar larvae were dissected and fixed for 1 hour at RT in 4% paraformaldehyde. 
They were then washed twice for 15 min with PBS containing 0.1% Triton X-100 
(PBST), blocked for 1 hour with PBS with 1% BSA. The samples were then 
incubated with anti-Wg (1:40; Developmental Studies Hybridoma Bank, Iowa) and 
anti-ȕ-gal (1:1000, Cappel) in blocking buffer, overnight at 4oC with rotation. The 
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next day the samples were washed twice with PBST for 15 min each following which 
they were incubated with AlexaFluor-488 goat anti-mouse antibody and AlexaFlour-
546 anti-rabbit antibody for 1 hour. The samples were then washed twice for 15 min 
each with PBST, following which the wing discs were mounted in Mowiol and stored 
at 4oC until imaging. Images were captured using Nikon Eclipse T1 confocal 
microscope with a 40X (N.A. 1.3) oil immersion objective.  
 For quantification of Wg levels, following projections of Z-stacks for each 
wing disc, regions of interest (ROIs) were marked inside the clone and ROIs of the 
same dimensions was marked on the neighbouring WT tissue. Measurement of 
intensities of Wg staining were obtained and the intensity per unit area was calculated 
IRUHDFKRIWKHPXWDQWDQG:752,'DWDZHUHDQDO\VHGXVLQJSDLUHG6WXGHQW¶Vt-test. 
 Dopaminergic neurons were analysed as described previously (37). Anti-
tyrosine hydroxylase (Chemicon AB152) was used at 1:200. Quantification was done 
with the experimenter blind to the genotype of the samples.  
 
Statistical Analysis 
Calculations and statistical analysis were performed using Excel (Microsoft 
Corporation, Redmond, WA), and Prism software (GraphPad Software Inc., San 
Diego, CA). Statistical significance was determined by one-way ANOVA with 
%RQIHUURQL¶VFRUUHFWLRQIRUPXOWLSOHFRPSDULVRQVRUE\6WXGHQW¶Vt-test. All data 
shown was obtained from at least 3 independent experiments. Lifespan and paraquat 
survival was analysed by Log-rank (Mantel-Cox) test. 
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Figure Legends 
Figure 1. No dominant toxicity of human or Drosophila Vps35 variants. (A) 
ClustalW2 Alignment of Vps35 amino acid sequence from human (hVps35) and 
Drosophila (dVps35) with the mis-sense mutations highlighted. (B) Immunoblot of 
human Vps35 transgenes raised at different temperatures to monitor relative 
expression levels. (C) Transgene expression does not affect lifespan when expressed 
ubiquitously with da-GAL4 (all not significant (ns) compared to control, Log-rank test, 
n = 40-100 animals). (D) No overt phenotype is see when the transgenes were 
expressed in the compound eye by GMR-GAL4. (E-G) Ubiquitous expression does 
not affect climbing ability with age (all not significant (ns) compared to control). n = 
25-40 (E), 20-40 (F), 10-40 (G). Histograms show mean ± s.e.m. Statistical analysis 
was one-way ANOVA with Bonferroni correction. Control genotypes are 
heterozygous GAL4 driver line alone.  
 
Figure 2. Variable effects of Vps35 variants to rescue synaptic overgrowth and 
locomotor phenotypes. (A) Anti-+53LPPXQRIOXRUHVFHQFHUHYHDOVµRYHUJURZQ¶
neuromuscular junctions in vps35 mutants. Scale bar = 10 µm. (B) Quantification 
shows significantly more synaptic boutons in vps35 mutants. n = 17-34 animals. All 
transgenes (Tg) provide a significant complete rescue of this phenotype. (C) vps35 
mutants display defective larval locomotion, measured by the number of peristaltic 
waves per 2 minutes. n = 5-14 animals. All transgenes provide some rescue of this 
phenotype but the variant forms are substantially less effective here. (D) Climbing 
assay of vps35 mutants expressing Drosophila vps35 transgenes. n = 30-46 animals. 
All animals were raised at 29oC. Statistical analysis: ns = not significant, * P<0.05, ** 
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P<0.01, *** P<0.001, **** P<0.0001; one-way ANOVA with Bonferroni correction. 
Control genotype is heterozygous da-GAL4 driver line alone.  
 
Figure 3. All transgenes rescue Wg secretion in vps35 mutants. (A) Anti-Wg 
immunostaining (green) reveals intracellular accumulation of Wg in FLP/FRT clones 
of vps35MH20 in wing imaginal discs. Loss of anti-ȕ-gal immunostaining (red) marks 
the clones lacking vps35. (B) Quantification of relative anti-Wg immunostaining in 
vps35 clones compared to neighbouring WT tissue. Histogram shows mean ± s.e.m. n 
= 15 ROIs from 9 animals. (C) Wing imaginal discs from vps35 null mutants in which 
hh-GAL4 drives expression of Vps35 transgenes in the posterior half along with an 
RFP marker (red). (D) Quantification of the relative immunofluorescence from 
anterior (mutant) versus posterior (rescued) segments of Wg expression domain. 
Histogram shows mean ± s.e.m. n = 5-6 discs per genotype, analysed by one-way 
ANOVA with Bonferroni correction (ns = not significant). Scale bar = 10 µm. 
 
Figure 4. vps35 genetically interacts with parkin. (A-F) Climbing ability was assessed 
at different ages in animals single and double heterozygous for null alleles of parkin 
(park25) and two independent null alleles of vps35, vps35MH20 (A-C) and vps35E42 (D-
F). n = 38-48 (A), 42-75 (B), 36-54 (C), 50-63 (D), 63-80 (E), 44-64 (F). (G) Survival 
analysis of single and double heterozygotes, alongside park25 homozygotes, exposed 
to 5 mM paraquat (PQ). n = 8-60 animals. (H) Analysis of dopaminergic neuron loss 
in the PPL1 cluster in 30 day old animals. n = 17, 22 and 16 respectively. Histograms 
show mean ± s.e.m. Statistical analysis: ns = not significant, ** P<0.01, *** P<0.001, 
**** P<0.0001; one-way ANOVA with Bonferroni correction, or log-rank test for 
survival.  
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Figure 5. Overexpression of vps35 rescues some parkin mutant phenotypes. 
Ubiquitous overexpression of all variants of Drosophila or human vps35 rescues 
parkin mutant climbing defect (A), but not the flight defect (B). n = 50-150 animals. 
Sensitivity of parkin mutants to 5 mM paraquat (PQ) exposure was completely 
rescued by transgenic expression of all variants of Drosophila (C) or human (D) 
vps35. n = 40-100 animals. Control genotype is heterozygous da-GAL4 driver line 
alone. Histograms show mean ± s.e.m. Statistical analysis: ns = not significant, ** 
P<0.01, *** P<0.001, **** P<0.0001; one-way ANOVA with Bonferroni correction, 
or log-rank test for survival. All comparison are with park25.  
 
Figure 6. vps35 does not genetically interact with pink1. (A-F) Climbing ability was 
assessed at different ages in animals single and double heterozygous for null alleles of 
pink1 (pink1B9) and two independent null alleles of vps35, vps35MH20 (A-C) and 
vps35E42 (D-F). n = 77-94 (A), 53-87 (B), 27-42 (C), 23-39 (D), 50-85 (E), 42-73 (F). 
(G) Overexpression of vps35 does not suppress climbing deficits in pink1 mutants (n 
= 60-100 animals), but slightly enhances the flight defect (H) (n = 35-60 animals). 
Histograms show mean ± s.e.m. Statistical analysis: ns = not significant, ** P<0.01, 
*** P<0.001, **** P<0.0001; one-way ANOVA with Bonferroni correction. 
Comparisons are with pink1 mutant control (pink1B9; da(GAL4)/+) unless otherwise 
indicated.  
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